Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Molecular subgrouping of medulloblastoma in pediatric population using the NanoString assay and comparison with immunohistochemistry methods

Fig. 2

A summary of molecular subgrouping by the NanoString assay and IHC of 101 patients with gene panel sequencing and clinical characteristics. IHC, Immunohistochemistry; WNT, Wingless signaling-activated; SHH, Sonic-hedgehog signaling-activated; NA, Not available. * ‘Unclassifiable’ in gene panel sequencing indicates absence of subgroup-defining genetic alterations such as mutations in CTNNB1 or SUFU gene

Back to article page